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Abstract Angiotensins (angiotensin I, angiotensin II, angioten- 
sin II-amide) have been isolated in leeches and such peptides are 
involved in diuresis in these animals. To explore possible 
inactivation mechanisms of these peptides, angiotensins were 
incubated with head membranes of the leech T. tessulatum. 
Membranes derived from head parts of this leech are very rich in 
peptidases. They contain endopeptidase-24.11-1ike enzyme 
(NEP-like) associated with a battery of exopeptidase. The way 
that angiotensins are degraded by the combined attack of these 
membrane peptidases has been investigated. The contribution of 
individual peptidases was assessed by adding inhibitors (phos- 
phoramidon, captopril and amastatin) to the membrane frac- 
tions, when they were incubated with the peptides. In the case of 
angiotensin I, the primary attack was performed by a combined 
action of the NEP-like and the ACE-like enzymes, followed by 
aminopeptidase attacks. Angiotensin II and III were hydrolyzed 
by NEP-like enzyme at the same Tyr-Ile bond, whereas the N- 
terminal arginine residue of angiotensin IH was removed by an 
arginyl aminopeptidase. These results show that angiotensins are 
efficiently degraded by membranes and that NEP-like enzyme 
plays a key role in this process. 
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1. Introduction 
Since immunocytochemical studies with polyclonal antisera 
raised against angiotensin II (a-All) at the level of the leech 
Theromyzon tessulatum brain, evidence was given of neurons 
containing angiotensin-like material [1]. This material was iso- 
lated from T. tessulatum and corresponded to the vertebrate 
AII and AIII, as well as fragments (3-8) and (6--8) of A l l  [2], 
suggesting the existence of peptidases involved in the metabo- 
lism of AII. Moreover, in Erpobdella octoculata, an angioten- 
sin II-amide, differing from the vertebrate AII by a carboxy- 
terminal amidation, has been sequenced [3]. Although the 
All-l ike peptide is very similar to the vertebrate All, its pre- 
cursor seems to be different from the vertebrates one, the 
angiotensinogen protein of ca. 60 kDa. Western blot analyses 
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performed with T. tessulatum central nervous systems (CNS) 
homogenate have revealed the existence of a multiple hor- 
mone AII-like precursor of ca. 19 kDa [2]. This protein pos- 
sesses at least four epitopes recognized by three different poly- 
clonal antisera (an anti-y-MSH, an anti-angiotensin I and an 
anti-angiotensin II) and by a monoclonal antibody (Tt159) 
specific for epitopes contained in T. tessulatum supraesopha- 
geal ganglia [2]. Three of the four epitopes recognized have 
been identified. The N-terminal part of a fragment of this 
precursor has recently been determined and the first 14 amino 
acid residues (DRVYIHPFHLLXWG) reveal the existence of 
both angiotensin I and angiotensin II [4]. The third epitope is 
a peptide related to the vertebrate y1-MSH [5]. The fragment 
of the All-l ike precursor presents in its sequence the proces- 
sing sites of the metabolic enzymes: renin and angiotensin- 
converting enzyme (ACE) [4]. These two enzymes have been 
isolated and our findings demonstrate that these ectopepti- 
dases are close to the renin and the ACE found in vertebrates, 
in activity, mass and N-terminal sequence [6,7], and are loca- 
lized at the level of the dorsal commissure and glial cells (un- 
published ata). A renin-angiotensin-like system (RAS) simi- 
lar to vertebrate RAS exists in leeches. Parallel to this RAS, a 
non-RAS would also be present in leeches. A neuropeptide 
endopeptidase of ca. 45 kDa (NEP-like enzyme) with charac- 
teristics close to those of endopeptidase-24.11 has been iso- 
lated from T. tessulatum head membranes [8]. 
Considering the existence of these two systems (RAS and 
non-RAS) in leeches, the aim of this work was to identify the 
different peptidases involved in angiotensins metabolism and 
to locate their sites of attack on these peptides. 
2. Material and methods 
2.1. Animals 
Mature specimens of the rhynchobdellid leech T. tessulatum, reared 
under laboratory conditions as described by Malecha et al. [9], were 
used in this study. 
2.2. Materials 
Angiotensin I (DRVYIHPFHL: AI), angiotensin II (DRVYIHPF: 
All), angiotensin III (RVYIHPF: AIII), DRVY, IHPF, HL, 
DRVYIHP, RVYIHP, VYIHPF, RVY, FHL peptides, the phenyla- 
lanine (F) residue, amastatin, captopril and phosphoramidon were 
obtained from Sigma. 
2.3. Antisera 
Two polyclonal antisera directed either against All (a-All) or 
against AI (a-AI) were generated in rabbits using synthetic human 
AII or AI coupled to human serum albumin via glutaraldehyde. Their 
specificity has been described elsewhere [1,4]. In brief, for a-All, 100% 
cross-reaction with All and 0.46% for AI were obtained. For a-AI, 
100% cross-reaction with AI, 10% for All and 0% for the synthetic 
porcine angiotensinogen tetradecapeptide (DRVYIHPFHLLVYS) 
were observed. 
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2.4. Immunoassays 
Dot immunobinding assay (DIA) and enzyme linked immunosor- 
bent assays (ELISAs) were based on the protocols of Salzet et al. 
[10,11]. 
2.5. Membrane preparation 
After anesthesia of the animals in 0.01% chlorobutanol, head parts 
of T. tessulatum were excised, immediately frozen in liquid nitrogen 
and stored at -70°C. 500 head parts (5 g) were placed in 25 ml TBS 
(20 mM Tris/HC1, pH 7.4, containing 200 mM NaCl) and homoge- 
nized at 4°C with a polytron (5 × 15 s bursts on setting 9). After 30 
min centrifugation at 10000 rpm at 4°C, the pellet was reextracted six 
times with the same amount of saline solution. The combined super- 
natants were centrifuged at 20000 rpm for 1 h at 4°C to yield a 
membrane pellet. These membranes were washed by resuspension i  
TBS, followed by sedimentation at 20000 rpm. The washing proce- 
dure was repeated until a clear supernatant was obtained. The washed 
membranes were resuspended in TBS and stored at -20°C. Protein 
concentration was determined with the Bradford procedure using ~/- 
globulin as standard [12]. 
automatic sequencer (Applied Biosystems, model 473A). Molar ratios 
of the products were calculated from data given by Stephenson and 
Kenny [14] on the quantification of peptides by HPLC. 
2.8. Inhibitor experiments 
Phosphoramidon, captopril and amastatin were used at a final con- 
centration of 10 I.tM and were preincubated for 30 min at 37°C with 
membranes before addition of 10 lal of the peptide solution. These 
inhibitors are respectively specific for endopeptidase-24.11 [ 5], ACE 
[16] and aminopeptidases [17]. 
2.9. Kinetics of degradation 
Kinetic parameters were determined from the regression line fitted 
to the data plotted as 1/V vs. I/[S]. Correlation coefficients were great- 
er than 0.99 [18]. K~at values were calculated assuming a molecular 
weight of 45 kDa for the purified NEP-like enzyme [8]. 
3. Results and discussion 
2.6. Identification of cleavage sites 
Assays of peptidase activities were carried out with 15 ~tg of mem- 
branes incubated or not with 10 ~tM peptides and 10 IxM inhibitors in 
TBS with a total volume of 100 ~tl. Reactions were terminated by 
addition of 30% trifluoroacetic acid (v/v). Samples were centrifuged 
at 12000 rpm for 15 min. Supernatants were diluted by adding 100 ~tl 
of 0.1% (v/v) trifluoroacetic acid and degraded fragments were ana- 
lyzed on a narrow-bore Cis (250 mm × 2 mm, Beckman) HPLC col- 
umn, with a linear gradient of acetonitrile in acidified water (0.1% 
trifluoroacetic acid) from 0 to 80% in 30 min at a flow rate of 300 
~tl/min. Emerging peaks were detected by absorbance at 215 nm and 
collected manually before being dried in vacuo. 
2. 7. Analysis of peptide products 
Identification of the metabolized products of the angiotensins was 
performed (a) by coelution with marker peptides in reversed-phase 
HPLC [13], (b) by reaction with specific antisera in immunoassays 
(DIA and/or ELISA) and (c) by Edman degradation on a pulse-liquid 
Results obtained with head membrane preparations are 
identical to those obtained with membrane preparations of 
CNS. However, in order to have sufficient material for these 
studies, head parts including the whole of the CNS were used. 
3.1. Metabolism of angiotensins 
After 1 h incubation of AI, A l l  and AI I I  peptides with 
membranes, the three angiotensins yielded multiple products 
which were collected, then dried in vacuo. The peptides or 
amino acids identified using ELISA, coelution with marker 
peptides and microsequencing are shown in Table 1. 
3.2. Effect of inhibitors on the pattern of angiotensin hydrolysis 
(Table 1) 
In trying to understand the way in which angiotensins are 
Table 1 
Effect of inhibitors on the hydrolysis of angiotensins by T. tessulatum head membranes 
Peptide Retention time Product formed Peptide remaining (%) 
(min) in the absence 
of inhibitor Phosphoramidon Captopril 




HL 3.3 1.66 70 52 48 
F 3.9 1.3 8 93 20 
IHP 4.8 0.8 12 100 100 
DRVY 6.4 1.5 12 100 100 
DRVYIHP 10.3 1.2 13 100 100 
VYIHP 11.5 0.3 32 95 100 
FHL 12.7 1.75 15 88 100 
DRVYIHPF 15.3 2.53 60 25 100 
Angiotensin H
HP 2.7 1.68 80 95 30 
F 3.6 1.45 86 100 80 
DRVY 6.2 2.6 3 100 100 
HPF 7.5 1.2 2 100 100 
DRVYIHP 10.7 0.78 100 100 100 
RVYIHPF 11.3 0.5 100 100 30 
IHPF 11.7 2.3 4 100 100 
Angiotensin III 
F 3.8 1.8 80 100 100 
RVY 4.5 2.8 5 100 100 
RVYIHP 9.9 0.7 100 100 100 
IHPF 11 3.2 12 100 100 
VYIHPF 11.8 0.8 100 100 34 
See section 2 for details. The amount of each product formed in 60 min in the absence of inhibitors is given in nmol h -1 mg protein - i .  The 
effect of each inhibitor on the product yield is expressed as a percentage of this value. The data are based on four experiments. 
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Fig. 1. Identities of the products formed by incubation of angioten- 
sins with T. tessulatum embranes. The numbered peptides corre- 
spond to the HPLC peaks and were identified by coelution with 
peptide markers in HPLC, antisera recognition and spectral scan- 
ning comparison. (1) DRVYIHPF; (2) HL; (3) F; (4) FHL; (5) 
DRVYIHP; (6) DRVY; (7) IHP; (8) VYIHP; (9) IHPF; (10) 
HPF; (11) RVYIHPF; (12) RVY; (13) RVYIHP; (14) VYIHPF. 
The enzymes acting on the angiotensin metabolism are the follow- 
ing: ACE: angiotensin-converting enzyme; AP: aminopeptidase; 
Asp-AP: aspartyl aminopeptidase; Arg-Ap: arginyl aminopeptidase; 
CP: carboxypeptidase; DPAP: dipeptidyl aminopeptidase; NAP: 
neutral aminopeptidase; NEP: neuropeptide-degrading endopepti- 
dase. 
metabolized by leech membranes, we can be hampered by 
some degree of ignorance concerning enzymes that may be 
involved. However, three enzymes have previously been well 
characterized in T. tessulatum head membranes: the renin- 
like, the ACE-like, and the endopeptidase-24.1 l-like (NEP- 
like) enzymes [6-8]. This background knowledge gives us 
some confidence in attributing the attack to one or more of 
the peptidases known to be present in T. tessulatum head 
membranes. Such conclusions clearly depend on the specificity 
of the inhibitors employed. By employing 10 ~tM phosphor- 
amidon, the leech NEP activity completely disappears. By 
contrast, the ACE-like enzyme remains active. 10 p.M capto- 
pril are sufficient o stop the leech ACE activity but have no 
effect on the NEP-like enzyme. In the case of the aminopep- 
tidases (AP), amastatin, a potent inhibitor [8], was used and 
blocked at least the neutral aminopeptidase (NAP) (unpub- 
lished data). 
3.2.1. Angiotensin I (Fig. la). The main product (DRV- 
YIHPF: AII) resulting from hydrolysis of the PheS-His 9bond 
was suppressed for 75% by captopril, 40% by phosphorami- 
don and 95% by a cocktail of phosphoramidon a d captopril, 
reflecting attack by both ACE-like and NEP-like enzymes. 
Hydrolysis at the ProT-Phe s bond yielding the DRVYIHP 
peptide was suppressed for 87% by phosphoramidon a d un- 
affected by other inhibitors. The second fragment (FHL) 
yielded by this attack was transitorily detected and was ra- 
pidly metabolized to HL peptide and Phe residue. The pro- 
duction of the peptide HL was suppressed for 58% by capto- 
pril and only 30% by phosphoramidon. This peptide is 
generated by both the ACE-like and the NEP-like enzymes 
followed by an AP attack inhibited by amastatin, liberating 
the Phe residue. Peptides DRVY and IHP from attacks at 
Tyra-Ile 5 and Pro7-Phe s bonds by a NEP-like enzyme were 
about 88% suppressed by phosphoramidon. The N-terminal 
dipeptide DR was not detected, even in the presence of amas- 
tatin. However, peptide VYIHP has been isolated, reflecting 
an attack at the Arg2-Val 3 bond by a dipeptidyl aminopepti- 
dase (DPAP). 
3.2.2. Angiotensin H (Fig. lb). Conversion of AII (DRV- 
YIHPF) in AII I  (RVYIHPF) by cleavage at the Aspl-Arg 2 
bond is about 70% suppressed by amastatin reflecting an at- 
tack by an aspartyl aminopeptidase (Asp-AP). However, the 
main attack on AII occurs at the Tyr4-Ile 5 bond generating 
DRVY and IHPF peptides. This attack is wholly suppressed 
by phosphoramidon. The IHPF peptide was rapidly degraded 
to either IHP and F or HPF. Appearance of these peptides is 
inhibited by phosphoramidon and amastatin, reflecting a 
NEP-like enzyme and an AP action, successively. None of 
the inhibitors used suppressed the formation of DRVYIHP. 
As compared to what is found in vertebrates, these results 
could be consistent with a degradation by a carboxypeptidase 
P which hydrolyses Pro-Xaa bonds [14,19]. 
3.2.3. Angiotensin III (Fig. lc). Three points of primary 
attack were revealed. The N-terminal arginine residue was 
removed to yield the VYIHPF peptide, partially suppressed 
by amastatin. Phenylalanine was released from the C-termi- 
nus, and this cleavage was inhibited 20% by phosphoramidon. 
The main attack was at the Tyra-Ile 4 bond, yielding the RVY 
and the IHPF peptides and this was strongly inhibited (88%) 
by phosphoramidon. 
3.3. Site of attack (Table 2) 
3.3.1. Angiotensin I. In addition to the conversion of AI 
to AII  by the combined action of ACE-like and NEP-like 
enzymes at the PheS-His 9 bond, during the first 15 min, AI 
is degraded by the NEP-like enzyme at the TyrI-Ile 5 and Pro 7- 
Phe s bonds. Then, between 15 and 30 min, this last event 
becomes the most important and peptide products are further 
degraded by a DPAP which attacks at the Arg 2 level and by a 
neutral aminopeptidase (NAP) (recently characterized, unpub- 
lished data) which cleaves at the Phea-His 9 bond the metabo- 
lized product (FHL) coming from the previous NEP-like en- 
zyme attack. 
3.3.2. Angiotensin II. AII, one of the biologically active 
peptides in leeches, is only degraded at 50% when 30 min 
have elapsed. AII  is firstly cleaved by an asparagyl aminopep- 
tidase (Asp-AP) which carries off the Asp 1 amino acid in AIII, 
then by the NEP-like action on the same bonds as in the 
second attack of the AI. The latter enzyme seems to cleave 
at the Ile 5 level. Early in the course of the reaction, a carbox- 
ypeptidase begins to take off the Phe s residue, which inacti- 
vates AII. 
3.3.3. Angiotensin III. The Asp-AP already mentioned at- 
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Table 2 
Time course of formation of peptides upon treatment with T. tessu- 
latum head membranes 
Peptide Incubation time (min) 
0 5 10 15 30 45 60 
Angiotensin I 8.8 8 6 5 2.6 2 
HL 0.3 0.8 1.2 1.4 
F 0.9 1.1 1.1 
IHP 0.05 0A 0.1 0.3 0.4 0.5 
DRVY 0.2 0.5 0.8 1.1 1.5 1.5 
DRVYIHP 0.3 0.6 0.9 1.2 1.1 
VYIHP 0.1 0.2 
FHL 0.1 0.4 0.7 0.9 0.9 1.4 
DRVYIHPF (All) 0.5 1.2 1.4 1.4 1.7 2.1 
Angiotensin H 9.5 9.3 8 6.8 5 2.2 
HP 0.2 1.2 1.7 
F 0.05 0.1 0.2 0.7 1 1.5 
DRVY 0.5 1.3 1.6 2.6 
HPF 0.6 0.8 1.2 1.2 
DRVYIHP 0.1 0.1 0.2 0.4 0.5 0.8 
RVYIHPF 0.3 0.5 0.8 0.6 0.5 0.5 
IHPF 0.5 0.8 1.3 1.7 2.3 
Angiotensin III 10.5 10 9.2 7 5.1 2.4 
F 0.3 0.8 1.2 1.9 
RVY 0.8 1.5 2.2 3.3 
RVYIHP 0.1 0.4 0.5 0.7 0.9 
IHPF 0.1 0.6 1.3 1.6 2.5 3.2 
VYIHPF 0.5 0.6 0.6 0.7 0.8 0.9 
See section 2 for details. Samples were incubated at 37°C for 0, 5, 
10, 15, 30, 45, 60 min. The amount of each product formed is given 
in nmol. 
tacks the Aspl-Arg 2 bond of AII to produce AIII, the other 
active angiotensin leeches [1]. As soon as AIII is yielded, 
the first enzymes to begin its degradation are an arginyl ami- 
nopeptidase (Arg-AP) and then the NEP-like enzyme. Indeed, 
VYIHPF (AIV) is the major product obtained after 5 min. By 
contrast, after 10 min, the amount of VYIHPF is constant 
while IHPF has greatly increased. 
3.3.4. Summary of the kinetic scheme (Fig. 1). Finally, it 
appears to us that the main attack is done by the NEP-like 
enzyme. The metabolized products are then degraded by AP 
in a secondary attack. The AP attacks, at the Phe-Xaa, the 
Arg-Xaa and the Asp-Xaa bonds, would not be performed by 
the same AP. According to the background knowledge in 
vertebrates, two types of AP could be implicated in such clea- 
vages, i.e. a NAP and acidic aminopeptidases [19]. In leech 
membrane, an enkephalin-degrading aminopeptidase close to 
the NAP has been isolated and characterized (unpublished 
data). This enzyme cleaves peptides at the Tyr-Xaa, Phe- 
Xaa bonds and could also be implicated in degradation of 
angiotensins at the Phe-Xaa bond. The other cleavages at 
the Arg-Xaa and Asp-Xaa could be due to acid aminopepti- 
dases as in vertebrates. 
3.4. Comparison of kinetic constants for purified NEP-like 
enzyme 
Purified NEP-like enzyme according to Laurent and Salzet 
[8] was used to follow the hydrolysis of angiotensins. With a 
Km of 72 gM for AI, 110 gM for All and 85 gM for AIII 
occurring at the ProT-Phe 8 and Tyr4-Ile ~ bonds of angioten- 
sins, these values are in line with those obtained on bradyki- 
nin (92 gM), lysylbradykinin (186 gM), and substance P (32 
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gM) with vertebrate NEP [14,18]. However, among the three 
angiotensins, the NEP-like enzyme seems to cleave preferen- 
tially AII, then AIII and AI. Koat values (4480 min-1; 5225 
rain-l;  4259 min -1) obtained for angiotensins AI, Al l  and 
AIII, respectively confirm the preceding hypothesis. NEP- 
like Kcat values are in line with those registered with verte- 
brate NEP on bradykinin (6360 min -1) or substance P (5060 
min -1) [18]. The ratio KcatlKm (106/mol per min) correspond- 
ing to the catalytic efficiency of the enzyme are the following: 
62.2, 47.5, 50.1 for AI, AII and AIII, respectively. Compared 
to Km values, NEP-like Kcat/Km reflects a better efficiency of 
this enzyme towards AI than towards AIII and AII. These 
results could be explained by the fact that NEP-like enzyme 
attacks AI at the level of three bonds instead of two bonds in 
the case of AII and AIII. In AI, cleavages mediated by NEP- 
like enzyme were on the amino side of F and are consistent 
with the known specificity of vertebrate NEP, for cleavages on 
the amino side of hydrophobic residues [18]. Moreover, as 
regards experiences conducted with vertebrate NEP on differ- 
ent substrates, the ratio Kcat/Km changes with the substrate 
used, e.g. Kcat/Km: 69 for bradykinin, 16.7 for lysylbradyki- 
nin, 158 for substance P [14,18]. As suggested by Rosenbaum 
et al. [18], residues in the P2 through P4 positions also con- 
tribute to substrate binding, whereas those in a more N-term- 
inal position contribute little to this process. The kinetics of 
degradation of AII and AIII are equivalent, because they 
possess the same N-terminal sequence xcept for a lack of 
an Asp residue in AIII. In the case of AI, its N-terminal 
part is identical to the ones of AII and AIII, but its C-term- 
inal side is different. Its C-terminal extension (FHL) allows 
the NEP-like enzyme to attack the Phe residue at both sides 
(N and C). These arguments could explain the degradation 
kinetics constants of AI compared to those of AII and AIII. 
4. Conclusion 
In the first 15 rain, about 30% of AI, AII and AII are 
metabolized. However, among this 30% degradation, a high 
percentage, ca. 20%, is attributed to the conversion of AI into 
AII, of AII into AIII and of AIII into AIV, the three active 
peptides in leech osmoregulation [1]. These results are in line 
with those of Zerbst-Boroffka [20]. This author has demon- 
strated by physiological experiments conducted in Hirudo 
medicinalis an 8-fold increase of the urine volume excreted 
15 min after a blood meal, which persisted for many hours. 
Moreover, we have established that the AI! amount greatly 
increased just after a blood meal [1] and we speculate that 
AII, AIII and IV increase diuresis by acting on their different 
targets as tegument, stomach or nephridia [1,3]. These data 
allow us to present the kinetic scheme of the relations existing 
between a blood meal, effective diuresis and the central ner- 
vous system (CNS) in which the angiotensin metabolism takes 
place. According to Wenning [21], stimulation of abdominal 
stretch receptors during feeding would cause hormonal release 
from the CNS. One of the hormone systems implicated in 
such a phenomenon is the angiotensins in leeches [1-3]. If 
we try to connect his physiological event to the enzymes 
involved in metabolism of angiotensins in CNS, we can dis- 
tinguish three implicated enzymes: the ACE-like, the NEP- 
like enzymes and the AP whose efficiencies are in line with 
those of vertebrates [19]. 
The main enzyme participating in the degradation of the 
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angiotensins is the NEP-like enzyme. This peptidase acts 
firstly to yield the AII  and secondly to inactivate AI, Al l ,  
AIII, by the action at Tyr4-Ile 5 and ProT-Phe 8 bonds. The 
metabolized products are then cleaved by the action of AP. 
These enzymes could constitute the degradative pattern of 
angiotensins. In addition, our findings have led us to discover 
the existence of a different AP, confirmed with the use of 
amastatin. First, a DPAP seems to play a role at the N-term- 
inal side of AI and its existence in invertebrates is sustained by 
recent results obtained in Cnideria [22]. Moreover, existence 
of an Asp-AP is sustained by the presence of AII I  and by its 
diuretic activity in T. tessulatum [1]. For the Arg-AP, we es- 
tablished its presence in head membranes by detection of the 
AIV peptide. These different enzymes would be implicated at 
a high level in degradation of AI, AII and AIII, 30 min after 
their release and could be activated by a feedback after AII 
action on its targets. However, only the localization of these 
enzymes in the CNS would allow us to confirm this hypothesis 
and further immunocytochemical experiences with antisera 
raised against hese purified enzymes are needed. 
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